Motus GI Holdings, Inc. MOTS

Company Overview

Motus GI Holdings, Inc. is a medical technology company focused on improving visualization and procedural efficiency during gastrointestinal endoscopy procedures. The company operates within the healthcare technology and medical devices industries, with its primary commercial focus centered on technologies designed to enhance colonoscopy preparation and reduce procedural inefficiencies caused by inadequately cleansed colons. Its core product platform has been the Pure-Vu System, a device designed to enable intraprocedural cleansing of the colon during colonoscopy procedures.

The company’s primary revenue drivers have historically included sales and placements of the Pure-Vu System and related disposable components used in hospital and endoscopy settings. Motus GI has primarily targeted hospitals, ambulatory surgical centers, and gastroenterology providers, particularly in cases involving hospitalized patients where bowel preparation challenges can delay diagnosis or treatment. The company has positioned itself around procedural efficiency and improved visualization in difficult-to-cleanse colonoscopy cases. Motus GI was founded in Israel and later established operations in the United States, evolving from an early-stage medical device developer into a publicly traded healthcare technology company listed on Nasdaq under the ticker MOTS. Public filings indicate the company has faced ongoing commercialization and financing challenges common among emerging medical device firms.